Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Successful recanalization of total occlusion: No improvement of long-term survival

Original Title: Successful Recanalization of Native Coronary Chronic Total Occlusion Is Not Associated With Improved Long-Term Survival.
Reference: Pil Hyung Lee et al. J Am Coll Cardiol Intv. 2016. Online before print.

 

The aim of this study was to assess long term clinical outcomes after successful recanalization of chronic total occlusion (CTO) with DES implantation.

Between March 2003 and May 2014, 1173 native coronary CTO consecutive patients undergoing PCI were analyzed. DES were implanted in all successful procedures (1,004 patients, 85.6%).

At a median follow up of 4.6 years, all-cause mortality risk (HR: 1.04; IC 95% 0.53 to 2.04; p=0.92) and the combined risk of death and infarction (HR: 1.05 IC 95% 0.56 a 1.94; p=0.89) were comparable between successful and unsuccessful recanalization patients.

Neither were there differences between those patients with other compromised vessels, in addition to the one totally occluded (n=879), receiving complete revascularization, vs. those with incomplete revascularization for unsuccessful recanalization.

These finding were consistent between patients with multivessel disease and those with only the one occluded vessel.

Conclusion
Successful recanalization of CTO compared to unsuccessful recanalization was not associated with a reduction of hard events, such as death. However, successful recanalization was associated to a significate lower chance of CABG following CTO.

Editorial Comment
The different strategies to treat severely compromised, yet not occluded, vessels, the high rate of surgery following unsuccessful recanalization, and the high successful rate with very few serious complications, all contributed to the neutral outcome of this study.

The real prognostic impact of recanalizations should be decided between successful PCI vs. optimal medical treatment.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...